Ciprofibrate
![]() | |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | C10AB08 (WHO) |
Identifiers | |
| |
CAS Number | 52214-84-3 |
PubChem (CID) | 2763 |
IUPHAR/BPS | 3438 |
ChemSpider |
2661 ![]() |
UNII |
F8252JGO9S ![]() |
KEGG |
D03521 ![]() |
ChEBI |
CHEBI:50867 ![]() |
ChEMBL |
CHEMBL557555 ![]() |
ECHA InfoCard | 100.052.478 |
Chemical and physical data | |
Formula | C13H14Cl2O3 |
Molar mass | 289.154 g/mol |
3D model (Jmol) | Interactive image |
Chirality | Racemic mixture |
| |
| |
(verify) |
Ciprofibrate is a fibrate that was developed as a lipid-lowering agent.
References
GI tract |
| ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Liver |
| ||||||||||
Blood vessels |
| ||||||||||
Combinations | |||||||||||
Other | |||||||||||
|
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.